For citations:

Kruglova L.S., Hotko A.A. Choice of first-line genetically engineered biological drugs for moderate and severe psoriasis in patients with comorbid pathology. Medical alphabet. 2020;(24):18-22. (In Russ.) https://doi.org/10.33667/2078-5631-2020-24-18-22